Medicamen Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

12.65

12.22

12.22

12.22

11.70

Share application money

1.13

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

180.02

135.82

122.14

110.26

74.93

Loan funds

Secured loans

24.18

24.35

17.33

9.97

11.63

Unsecured loans

-

-

-

-

-

Total

217.98

172.39

151.69

132.45

98.27

Uses of funds

Fixed assets

Gross block

129.45

123.70

115.20

57.34

46.25

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

37.08

31.22

25.56

23.65

21.87

Net block

92.36

92.48

89.64

33.69

24.38

Capital work-in-progress

-

-

-

40.50

14.76

Investments

4.08

2.06

2.06

2.06

-

Net current assets

Current assets, loans & advances

180.34

131.16

100.77

100.20

97.45

Less : current liabilities & provisions

58.80

53.31

40.78

44.00

38.32

Total net current assets

121.54

77.85

59.99

56.20

59.13

Miscellaneous expenses not written

-

-

-

-

-

Total

217.98

172.39

151.69

132.45

98.27

Notes:

Book value of unquoted investments

4.08

2.06

2.06

2.06

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

8.56

5.85

4.73

6.35

5.18

Number of equity sharesoutstanding (Lacs)

126.51

122.17

122.17

122.17

117.00